Advances in Neuromodulation

Neuromodulation is the physiological process by which a given neuron uses one or more chemicals to regulate diverse populations of neurons. Neuromodulators typically bind to metabotropic, G-protein coupled receptors (GPCRs) to initiate a second messenger signaling cascade that induces a broad, long-lasting signal. This modulation can last for hundreds of milliseconds to several minutes. Some of the effects of neuromodulators include altering intrinsic firing activity, increasing or decreasing voltage-dependent currents, altering synaptic efficacy, increasing bursting activity and reconfiguring synaptic connectivity.

In the present book, thirteen typical literatures about neuromodulation published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on neuromodulation. We hope this book can demonstrate advances in neuromodulation as well as give references to the researchers, students and other related people.

Sample Chapter(s)
Preface (179 KB)
Components of the Book:
  • Chapter 1
    Neuromodulation of Attention
  • Chapter 2
    Compartment-specific dendritic information processing in striatal cholinergic interneurons is reconfigured by peptide neuromodulation
  • Chapter 3
    Opportunities of connectomic neuromodulation
  • Chapter 4
    Neuromodulation for Brain Disorders: Challenges and Opportunities
  • Chapter 5
    Ultrasound Neuromodulation: A Review of Results, Mechanisms and Safety
  • Chapter 6
    Neuromodulation of chronic headaches: position statement from the European Headache Federation
  • Chapter 7
    Neuroinflammation mechanisms of neuromodulation therapies for anxiety and depression
  • Chapter 8
    Reliable neuromodulation from circuits with variable underlying structure
  • Chapter 9
    Towards network-guided neuromodulation for epilepsy
  • Chapter 10
    Neuromodulation of Neural Oscillations in Health and Disease
  • Chapter 11
    New Technologies and Applications in Sacral Neuromodulation: An Update
  • Chapter 12
    Non-Faradaic optoelectrodes for safe electrical neuromodulation
  • Chapter 13
    A systematic review and meta-analysis of neuromodulation therapies for substance use disorders
Readership: Students, academics, teachers and other people attending or interested in neuromodulation.
Alexander Thiele
Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK

Mark A. Bellgrove
Monash Institute of Cognitive and Clinical Neurosciences (MICCN) and School of Psychological Sciences, Monash University, Melbourne, Australia

Stephen R. Williams
Queensland Brain Institute, The University of Queensland, St. Lucia, QLD 4072, Australia

and more...
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top